Technology News and Research

RSS

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

ImaginAb, Inc. and Imanet have signed a master service agreement for pre-clinical and clinical imaging. This agreement supports the development strategy for ImaginAb's pipeline of next generation diagnostic imaging agents based on recombinant antibody fragments. The Imanet™ network of Positron Emission Tomography (PET) imaging sites provides assistance in all aspects of PET imaging-based clinical trials: from proof-of-concept radiochemistry to clinical imaging, with more than 40 PET research tracers.

11 Oct 2010

Zotec enters 3-year billing services contract with West Coast Radiology Centers

Zotec Partners, an industry leader in medical billing, practice management and Radiology Information Systems (RIS) software and services, announces today that West Coast Radiology Centers (WCRC), out of Santa Ana/Tustin, Calif., has inked a three-year billing services contract with the company. WCRC operates nine imaging centers throughout Orange County.

11 Oct 2010

TriReme Medical closes $17M Round D financing

TriReme Medical, a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the closing of a $17M Round D financing. The financing was led by Bio*One Capital, a subsidiary of Singapore based EDB Investments with strong support from current investors, Three Arch Partners and Adams Street Partners.

11 Oct 2010

Varian and Stanford scientists receive $3.6M NIH grant to develop advanced imaging technology

Scientists from Stanford University and from the Ginzton Technology Center at Varian Medical Systems have jointly received a $3.6 million five-year research grant from the U.S. National Institutes of Health (NIH) to develop advanced imaging technology for improving the quality of CT images for patients with metal objects in their bodies such as hip implants and dental fillings.

11 Oct 2010

Gelesis presents lead products data at Obesity 2010 Annual Meeting

Gelesis, Inc., a Boston-based company focused on breakthrough treatments for obesity, presented new results at Obesity 2010, the 28th Annual Scientific Meeting of The Obesity Society (San Diego). The new data demonstrated that its lead products (Attiva and Gellica) dramatically reduced food intake in a gold-standard animal model compared to administration of an equal amount of water.

11 Oct 2010

Agilex named region's fastest growing company by Washington Business Journal

Agilex Technologies, Inc., a leading provider of mission and technology solutions to the national security, healthcare and public sectors, announced today it was named the region's fastest growing company by the Washington Business Journal. In the company's first year of eligibility, Agilex debuted at the top of the list with reported three year growth of 372.32% and total revenue of $38M (FY2009). This annual ranking covers the entire Washington, DC metro area.

11 Oct 2010

Arable introduces CTMS and EDC software for clinical organizations

Arable Corporation has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry. Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS and EDC capabilities without the traditionally high start-up costs.

11 Oct 2010

TruTouch secures grant to accelerate development of next-generation technology platform

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has secured a $438,000 grant to accelerate the development of its next-generation technology platform.

11 Oct 2010

Prescription Solutions' MS DTM program wins URAC Best Practices Platinum Award

Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group company, received a platinum award in the URAC Best Practices in Health Care Consumer Empowerment and Protection Awards. Prescription Solutions was recognized for its Multiple Sclerosis Disease Therapy Management (MS DTM) program, which empowers patients through education and support to successfully attain skills in self-managing their symptoms and medication therapy for their chronic condition.

11 Oct 2010

Innate Therapeutics initiates MIS416 Phase 2a clinical study in patients with progressive multiple sclerosis

Innate Therapeutics today announced that the company has begun treating patients in a Phase 2a clinical study of its lead molecule, MIS416, in patients with progressive multiple sclerosis (MS).

11 Oct 2010

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Leading national researchers in the fight against breast cancer will convene Oct. 26-29 for the 2010 Advances in Breast Cancer Research Workshop at the University of Arkansas. More than 70 scientists from diverse research areas in science, medicine, engineering and technology will participate. Ten featured speakers will present cutting-edge research on breast cancer diagnosis, therapeutic techniques, treatment and screening.

11 Oct 2010

Weikang Bio-Technology reiterates fiscal 2010 revenue guidance, targets growth of 30% to 50% for fiscal 2011

Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.

11 Oct 2010

PlastiPure, ReliaBrand partner to produce EA-Free plastic consumer products

PlastiPure, a safer-plastics technology company, has announced a partnership with ReliaBrand to license infant feeding, sports bottle, food packaging, and medical products free of harmful chemicals that cause estrogenic activity (EA). Chemicals with EA have been strongly linked to adverse health effects such as birth defects, reproductive cancers, and behavioral and learning disorders. The widely known chemicals BPA and phthalates are only a few of thousands of chemicals suspected to have EA.

11 Oct 2010

Sec. of State Clinton, other officials launch initiative to provide mobile phones to 150M women in the developing world

Officials gathered in Washington, D.C. on Thursday to launch mWomen, an initiative aimed at increasing access to mobile phones to further health and development benefits among women in the developing countries, the Telegraph reports.

11 Oct 2010

ALung Technologies announces closing of $14 Million Series A financing round

ALung Technologies, Inc. today announced that the Company has closed a $14 Million Series A financing round. The investment will support ongoing clinical trials of the Hemolung™ Respiratory Assist System and its subsequent commercialization. The Company's Hemolung device is expected to help many patients with acute respiratory failure to avoid intubation and invasive mechanical ventilation.

11 Oct 2010

NIH awards La Jolla Institute $12.6M to develop San Diego's first Center for RNAi screening

The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening -- a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.

11 Oct 2010

Promising clinical data of ImmunoGen's lorvotuzumab mertansine to be presented at ESMO conference

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.

11 Oct 2010

Seattle Genetics reports SGN-75 phase I clinical trial data

Seattle Genetics, Inc. today reported data from a phase I clinical trial of SGN-75 in patients with non-Hodgkin lymphoma or renal cell carcinoma (RCC). Preliminary results demonstrate tolerability and antitumor activity, including two objective responses in the first 16 patients treated. Dose-escalation is continuing.

11 Oct 2010

CCHIT certifies Health Care Systems' eMR Version 4

Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

11 Oct 2010

Rutgers University receives NIH grant to increase reliability of prostate cancer imaging

The National Institutes of Health has awarded a $3.3 million grant to a research team that includes Rutgers University to increase the reliability of imaging prostate cancer.

11 Oct 2010

Technology News and Research

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

Zotec enters 3-year billing services contract with West Coast Radiology Centers

TriReme Medical closes $17M Round D financing

Varian and Stanford scientists receive $3.6M NIH grant to develop advanced imaging technology

Gelesis presents lead products data at Obesity 2010 Annual Meeting

Agilex named region's fastest growing company by Washington Business Journal

Arable introduces CTMS and EDC software for clinical organizations

TruTouch secures grant to accelerate development of next-generation technology platform

Prescription Solutions' MS DTM program wins URAC Best Practices Platinum Award

Innate Therapeutics initiates MIS416 Phase 2a clinical study in patients with progressive multiple sclerosis

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Weikang Bio-Technology reiterates fiscal 2010 revenue guidance, targets growth of 30% to 50% for fiscal 2011

PlastiPure, ReliaBrand partner to produce EA-Free plastic consumer products

Sec. of State Clinton, other officials launch initiative to provide mobile phones to 150M women in the developing world

ALung Technologies announces closing of $14 Million Series A financing round

NIH awards La Jolla Institute $12.6M to develop San Diego's first Center for RNAi screening

Promising clinical data of ImmunoGen's lorvotuzumab mertansine to be presented at ESMO conference

Seattle Genetics reports SGN-75 phase I clinical trial data

CCHIT certifies Health Care Systems' eMR Version 4

Rutgers University receives NIH grant to increase reliability of prostate cancer imaging

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News